Get startedLog in
    Picture of Kukje Pharma Co logo

    002720 — Kukje Pharma Co Cashflow Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapContrarian
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Kukje Pharma Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line2,195-1,5563,543-8,4155,206
    Depreciation
    Amortisation
    Non-Cash Items13,1884,2352,9645,7056,134
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-13,9092,499-4,4912,081-10,603
    Change in Accounts Receivable
    Change in Inventories
    Change in Accounts Payable
    Change in Other Liabilities
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities5,1009,5976,5043,5753,940
    Capital Expenditures-11,600-1,961-1,277-1,046-2,995
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items2,619-1,421-70.1-129-1,765
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Sale of Intangible Assets
    Other Investing Cash Flow
    Cash from Investing Activities-8,981-3,382-1,347-1,175-4,760
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities622-2,434-7,4742,610-1,198
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-3,4353,853-2,3275,051-1,911